ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

Commemoration Planned For Heidelberger

February 11, 1983

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

August 16, 1991

Estrogen Can Benefit Women With Metastatic Breast Cancer

January 30, 2009

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

Ratain To Lead New Center For Personalized Therapeutics At University of Chicago. Report Calls For Better Risk Stratification And New Name For DCIS.

January 22, 2010

NCI Grant Awards

October 8, 1993